| Stage | DVA | % of rev | PGNY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.6B | 100.00% | $341M | 100.00% | DVA ×10.49 |
| Gross profit | $1.1B | 31.50% | $84M | 24.54% | DVA +7.0pp |
| Operating income | $499M | 13.95% | $35M | 10.31% | DVA +3.6pp |
| Pre-tax income | $359M | 10.02% | $36M | 10.67% | PGNY +0.6pp |
| Net income | $269M | 7.53% | $26M | 7.69% | PGNY +0.2pp |
| Stage | DVA | PGNY | Gap · A − B |
|---|---|---|---|
| Revenue | $3.6B100.00% | $341M100.00% | DVA ×10.49 |
| Gross profit | 31.50%$1.1B | 24.54%$84M | DVA +7.0pp |
| Operating income | 13.95%$499M | 10.31%$35M | DVA +3.6pp |
| Pre-tax income | 10.02%$359M | 10.67%$36M | PGNY +0.6pp |
| Net income |
| 7.53%$269M |
| 7.69%$26M |
| PGNY +0.2pp |
No disclosed counterparties: PGNY.
None